Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Gains from Investment Securities (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Gains from Investment Securities for 4 consecutive years, with $176000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 88.91% to $176000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, down 46.26% year-over-year, with the annual reading at $4.8 million for FY2025, 9.91% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $176000.0 at Centessa Pharmaceuticals, up from $125000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $9.7 million in Q1 2023, with the low at -$206000.0 in Q4 2022.
  • Average Gains from Investment Securities over 4 years is $2.2 million, with a median of $970000.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 87.11% in 2025, while the deepest fall reached 88.91% in 2025.
  • Over 4 years, Gains from Investment Securities stood at -$206000.0 in 2022, then surged by 4814.08% to $9.7 million in 2023, then plummeted by 83.66% to $1.6 million in 2024, then tumbled by 88.91% to $176000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $176000.0, $125000.0, and $1.6 million for Q4 2025, Q3 2025, and Q4 2024 respectively.